SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
KYMR reported Third quarter ended September 30, 2026 results. The stock moved +0.1% on the print.
KYMRearnings

Earnings reactions, page 9

Kymera Therapeutics, Inc. (KYMR) Q3 FY2026 earnings

October 29, 2026 · SharpeIQ Research Desk

Reported results

  • Collaboration revenues were $0 for the third quarter of 2026 compared to $2.8 million for the third quarter of 2025.
  • Research and development expenses were $128.5 million for the third quarter of 2026 compared to $74.1 million for the third quarter of 2025.
  • General and administrative expenses were $18.7 million for the third quarter of 2026 compared to $17.3 million for the third quarter of 2025.
  • Net loss was $132.0 million for the third quarter of 2026 compared to $82.2 million for the third quarter of 2025.
  • Cash, cash equivalents and investments were $1.6 billion as of September 30, 2026.

Guidance

  • The Company does not expect to recognize additional collaboration revenue in 2026.
  • The Company expects that its cash balance will provide the Company with a cash runway into 2029.

Price and volatility reaction

The stock moved +0.1% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -6.5 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release122.512026-10-28
Close after release122.62026-10-29
Realised move+0.1%close to close
30d ATM IV change-6.5 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →